Clinical course in Crohn’s disease: factors associated with behaviour change and surgery

References

• Abegunde AT, Muhammad BH, Bhatti O, et al. Environmental risk factors for inflammatory bowel diseases: evidence based literature review. Wjg. 2016;22:6296–6317.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–217.
   PubMed Web of Science ®Google Scholar
• Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.
   PubMed Web of Science ®Google Scholar
• Gomollon F, Dignass A, Annese V, et al. 3rd European Evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. eccojc. 2017;11:3–25.
   Web of Science ®Google Scholar
• Aniwan S, Park SH, Loftus EV, Jr. Epidemiology, natural history, and risk stratification of Crohn’s disease. Gastroenterol Clin North Am. 2017;46:463–480.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Loftus EV, Jr., Colombel JF, et al. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–297.
   PubMed Web of Science ®Google Scholar
• Sachar DB. Behaviour of Crohn’s disease according to the Vienna classification. Gut. 2002;51:614.
   PubMed Web of Science ®Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.
   PubMed Web of Science ®Google Scholar
• Rebelo A, Rosa B, Moreira MJ, et al. From the Vienna classification to the new montreal classification: phenotype characterization and clinical evolution of Crohn’s disease. J Port Gastrenterol. 2011;18:15–21.
   Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.
   PubMed Web of Science ®Google Scholar
• Spekhorst LM, Visschedijk MC, Alberts R, et al. Performance of the montreal classification for inflammatory bowel diseases. WJG. 2014;20:15374–15381.
   PubMed Web of Science ®Google Scholar
• Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–250.
   PubMed Web of Science ®Google Scholar
• Magro F, Rodrigues-Pinto E, Coelho R, et al. Is it possible to change phenotype progression in Crohn’s disease in the era of immunomodulators? Predictive factors of phenotype progression. Am J Gastroenterol. 2014;109:1026–1036.
   PubMed Web of Science ®Google Scholar
• Ouaz A, Fekih M, Labidi A, et al. Changes of Crohn’s disease phenotype over time. Tunis Med. 2016;94:167–170.
   PubMedGoogle Scholar
• Loly C, Belaiche J, Louis E. Predictors of severe Crohn’s disease. Scand J Gastroenterol. 2008;43:948–954.
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Czegledi Z, Szamosi T, et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease. WJG. 2009;15:3504–3510.
   PubMed Web of Science ®Google Scholar
• Romberg-Camps MJ, Dagnelie PC, Kester AD, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104:371–383.
   PubMed Web of Science ®Google Scholar
• Cotter J, Dias de Castro F, Moreira MJ, et al. Tailoring Crohn’s disease treatment: the impact of small bowel capsule endoscopy. J Crohns Colitis. 2014;8:1610–1615.
   PubMed Web of Science ®Google Scholar
• de Barros KSC, Flores C, Harlacher L, et al. Evolution of clinical behavior in Crohn’s disease: factors associated with complicated disease and surgery. Dig Dis Sci. 2017;62:2481–2488.
   PubMed Web of Science ®Google Scholar
• Henriksen M, Jahnsen J, Lygren I, et al. Clinical course in Crohn’s disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol. 2007;42:602–610.
   PubMed Web of Science ®Google Scholar
• Irwin J, Ferguson E, Simms LA, et al. A rolling phenotype in Crohn’s disease. PloS One. 2017;12:e0174954
   PubMed Web of Science ®Google Scholar
• Louis E, Collard A, Oger AF, et al. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777–782.
   PubMed Web of Science ®Google Scholar
• Zhulina Y, Udumyan R, Tysk C, et al. The changing face of Crohn’s disease: a population-based study of the natural history of Crohn’s disease in Örebro, Sweden 1963–2005. Scand J Gastroenterol. 2016;51:304–313.
   PubMed Web of Science ®Google Scholar
• Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114–1122.
   PubMed Web of Science ®Google Scholar
• Freeman HJ. Long-term prognosis of early-onset Crohn’s disease diagnosed in childhood or adolescence. Can J Gastroenterol. 2004;18:661–665.
   PubMed Web of Science ®Google Scholar
• Freeman HJ. Comparison of longstanding pediatric-onset and adult-onset Crohn’s disease. J Pediatr Gastroenterol Nutr. 2004;39:183–186.
   PubMed Web of Science ®Google Scholar
• Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn’s disease. Gastroenterology. 2006;130:650–656.
   PubMed Web of Science ®Google Scholar
• Veloso FT. Clinical predictors of Crohn’s disease course. Eur J Gastroenterol Hepatol. 2016;28:1122–1125.
   PubMed Web of Science ®Google Scholar
• Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial. Lancet. 2002;359:1541–1549.
   PubMed Web of Science ®Google Scholar
• Ha F, Khalil H. Crohn’s disease: a clinical update. Therap Adv Gastroenterol. 2015;8:352–359.
   PubMed Web of Science ®Google Scholar
• Colombel JF, Panaccione R, Bossuyt P, et al. Effect of tight control management on Crohn’s disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2018;390:2779–2789.
   PubMed Web of Science ®Google Scholar
• Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350:876–885.
   PubMed Web of Science ®Google Scholar
• Chatu S, Saxena S, Subramanian V, et al. The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn’s disease: national UK population-based study 1989-2010. Am J Gastroenterol. 2014;109:409–416.
   PubMed Web of Science ®Google Scholar
• Kariyawasam VC, Selinger CP, Katelaris PH, et al. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn’s disease. Inflamm Bowel Dis. 2014;20:1382–1390.
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Golovics PA, David G, et al. Has there been a change in the natural history of Crohn’s disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977–2009. Am J Gastroenterol. 2012;107:579–588.
   PubMed Web of Science ®Google Scholar
• Agrez MV, Valente RM, Pierce W, et al. Surgical history of Crohn’s disease in a well-defined population. Mayo Clin Proc. 1982;57:747–752.
   PubMed Web of Science ®Google Scholar
• Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg. 2000;231:38–45.
   PubMed Web of Science ®Google Scholar
• Mao EJ, Hazlewood GS, Kaplan GG, et al. Systematic review with meta-analysis: comparative efficacy of immune-suppressants and biologics for reducing hospitalisation and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;45:3–13.
   PubMed Web of Science ®Google Scholar
• Frolkis AD, de Bruyn J, Jette N, et al. The association of smoking and surgery in inflammatory bowel disease is modified by age at diagnosis. Clin Trans Gastroenterol. 2016;7:e165.
   PubMed Web of Science ®Google Scholar
• Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology. 1996;110:424–431.
   PubMed Web of Science ®Google Scholar
• Pariente B, Cosnes J, Danese S, et al. Development of the Crohn’s disease digestive damage score, the Lemann score. Inflamm Bowel Dis. 2011;17:1415–1422.
   PubMed Web of Science ®Google Scholar